✦ LIBER ✦

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)

✍ Scribed by Hiroyuki Takei; Kimito Suemasu; Kenichi Inoue; Tsuyoshi Saito; Katsuhiko Okubo; Junichi Koh; Kazuhiko Sato; Hitoshi Tsuda; Masafumi Kurosumi; Toshio Tabei

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 228 KB
Volume: 107
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9529-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exemestane as primary systemic treatment

Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17)

✍ Brigitte Mlineritsch; Christoph Tausch; Christian Singer; Gero Luschin-Ebengreut 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB

Exemestane versus anastrozole as front-l

Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer : Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial

✍ Antonio Llombart-Cussac; Amparo Ruiz; Antonio Antón; Agustí Barnadas; Silvia Ant 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views